Turning Point Therapeutics
Biotechnology Research
San Diego, CA 13,494 followers
A precision oncology company, driven to develop therapies that mark a turning point for patients.
About us
We officially combined with Bristol Myers Squibb to advance our precision oncology platform for patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for cancer patients. For more information on the acquisition, read our press release at: bit.ly/3Uccbu8
- Website
-
http://www.bms.com
External link for Turning Point Therapeutics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- San Diego, CA
- Type
- Public Company
- Founded
- 2013
- Specialties
- Oncology, Structure-based design, Precision medicine, Drug resistance, NTRK, ROS1, ALK, NTRK1, NTRK2, NTRK3, SRC, FAK, JAK2, MASC, NSCLC, G1202R, G2032R, fusion gene, oncogenic, and metastasis
Locations
-
Primary
Get directions
10628 Science Center Drive
Ste. 200
San Diego, CA 92121, US